The Drug Synthesis and Chemistry Branch (DS&CB) of the Developmental Therapeutics Program (DTP) of the Division of Cancer Treatment (DCT) of the National Cancer Institute (NCI) is seeking contractors with chemical synthesis expertise to synthesis a variety of compounds for evaluation as potential anticancer agents. The objectives of this project are to: synthesize congeners of synthetic compounds with confirmed activity; design and synthesize """"""""pro-drugs"""""""" and other compounds that possess elements of both congener and pro-drug; and synthesize compounds related to products of natural origin and other related heterocycles.

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM027571-005
Application #
3610181
Study Section
Project Start
1982-09-30
Project End
1986-03-31
Budget Start
1985-03-31
Budget End
1986-03-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Alabama in Tuscaloosa
Department
Type
Schools of Arts and Sciences
DUNS #
City
Tuscaloosa
State
AL
Country
United States
Zip Code
35487
Moyer, J D; Reizes, O; Ahir, S et al. (1988) Substrate properties of analogs of myo-inositol. Mol Pharmacol 33:683-9
Baker, D C; Hand, E S; Plowman, J et al. (1987) Synthesis, chemical stability and pre-clinical anti-tumor activity of pyrazine diazohydroxide, sodium salt (NSC-361456). Anticancer Drug Des 2:297-309